Skip to Content

DaVita Healthcare Partners, Inc.

Company NameDaVita Healthcare Partners, Inc.
Stock SymbolDVA

The Firm announces that it is investigating potential claims on behalf of investors of DaVita Healthcare Partners, Inc. ("DaVita" or the "Company") (NYSE:DVA), concerning the Company and its officers’ possible violations of federal securities laws and/or breaches of fiduciary duty.

Please contact Lesley Portnoy at 888-773-9224 or 310-201-9150, or at shareholders@glancylaw.com to discuss this matter. If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.

On February 11, 2016, post-market, the company disclosed that it had received a Civil Investigative Demand (CID) from the U.S. Attorney's Office for the Northern District of Texas regarding a False Claims Act investigation into allegations that it submitted false claims to the government for prescription drug reimbursement dating back to January 1, 2006. On this news, the company's shares fell $1.99, or 3.18%, to $60.58 post-market on February 11, 2016.

If you purchased shares of DaVita, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of Glancy Prongay & Murray LLP, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224 or by email to shareholders@glancylaw.com.

Submit Your Information

If you suffered a loss on your DaVita Healthcare Partners, Inc. investments or would like to inquire about joining an action to recover your loss under the federal securities laws, please complete the form below.

An attorney will contact you at no cost to provide you information about joining the action and answer your questions. Please note that submission of this form does not by itself form an attorney-client relationship nor does filing out this form mean you have joined any lawsuit.

Shares Purchased

Number of SharesBuy DatePrice Per ShareAdd

Shares Sold

Number of SharesSell DatePrice Per ShareAdd